WO2023021330 - COMPOSITIONS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION
National phase entry is expected:
Publication Number
WO/2023/021330
Publication Date
23.02.2023
International Application No.
PCT/IB2022/000463
International Filing Date
15.08.2022
Title **
[English]
COMPOSITIONS AND METHODS FOR DETERMINING A TREATMENT COURSE OF ACTION
[French]
COMPOSITIONS ET MÉTHODES PERMETTANT DE DÉTERMINER UN PLAN D'ACTION THÉRAPEUTIQUE
Applicants **
UNIVERSITY OF OSLO
P.O. Box 1072, Blindern
NO-0316 Oslo, NO
Inventors
SVEEN, Anita
c/o University of Oslo
P.O. Box 1072, Blindern
NO-0316 Oslo, NO
MOOSAVI, Seyed, H.
c/o University of Oslo
P.O. Box 1072, Blindern
NO-0316 Oslo, NO
LOTHE, Ragnhild, A.
c/o University of Oslo
P.O. Box 1072, Blindern
NO-0316 Oslo, NO
Priority Data
63/233,452
16.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1834 | |
| EPO | Filing, Examination | 9290 | |
| Japan | Filing | 588 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 9310 |
Total: 21596 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to compositions, systems, and methods for determining a treatment course of action. In particular, the present invention relates to compositions, systems, and methods for utilizing gene expression profiles to determine drug sensitivity in colorectal cancer.[French]
La présente invention concerne des compositions, des systèmes et des méthodes permettant de déterminer un plan d'action thérapeutique. En particulier, la présente invention concerne des compositions, des systèmes et des méthodes permettant d'utiliser des profils d'expression génique pour déterminer la sensibilité aux médicaments dans des cas de cancer colorectal.